SCHEDULE: JPMorgan Chase & Co. Updates Passive Stake in Oscar Health, Inc.

JPMorgan Chase & Co. has filed an amended Schedule 13G, disclosing a 4.5% passive beneficial ownership stake in Oscar Health, Inc.'s Class A Common Stock.

Summary

• JPMorgan Chase & Co. holds an aggregate of 9,950,789 shares of Oscar Health, Inc. Class A Common Stock.
• This beneficial ownership represents 4.5% of the total Class A Common Stock outstanding.
• The ownership includes 9,258,561 shares with sole voting power and 9,907,930 shares with sole dispositive power.
• A smaller portion of 15,659 shares is held with shared dispositive power.
• The filing is an Amendment No. 1 to a previous Schedule 13G, indicating an update to a prior ownership disclosure.

Sentiment

Score: 5

Explanation: This is a neutral, factual disclosure of passive institutional ownership. While JPMorgan's continued stake is generally positive, the percentage being below 5% (and potentially a reduction from a prior filing) introduces a slight ambiguity, making it neutral overall.

Positives

• JPMorgan Chase & Co., a prominent financial institution, maintains a significant beneficial ownership in Oscar Health, Inc., which can be viewed as a continued vote of confidence in the company.

Negatives

• JPMorgan Chase & Co.'s beneficial ownership in Oscar Health, Inc. is now 4.5%, falling below the 5% threshold typically associated with significant passive stakes, which may indicate a reduction from a prior higher holding.

Risks

• No specific company-related risks are detailed in this ownership disclosure filing.

Future Outlook

This filing, a Schedule 13G, is an ownership disclosure by an institutional investor and does not contain forward-looking statements or guidance from Oscar Health, Inc.

Management Comments

• No direct quotes or paraphrased statements from Oscar Health, Inc. management are included in this ownership disclosure.

Industry Context

This Schedule 13G filing reflects a routine disclosure of passive institutional ownership by a major financial entity, JPMorgan Chase & Co., in a publicly traded healthcare technology company, Oscar Health, Inc. It does not provide broader industry trends or competitive analysis.

Comparison to Industry Standards

• This filing is a disclosure of beneficial ownership and does not contain information for comparison to industry standards or specific comparable companies/projects.

Stakeholder Impact

• Shareholders may note the continued passive institutional interest from JPMorgan Chase & Co. in Oscar Health, Inc. No other direct impacts on employees, customers, suppliers, or creditors are indicated by this ownership filing.

Next Steps

• No specific future actions, events, or milestones for Oscar Health, Inc. are mentioned in this ownership disclosure.

Key Dates

Keywords

Oscar Health, JPMorgan Chase, Schedule 13G, Beneficial Ownership, Class A Common Stock, Institutional Investor, Passive Stake